Published in Am J Med Genet A on January 15, 2008
Low rates of African American participation in genetic counseling and testing for BRCA1/2 mutations: racial disparities or just a difference? J Genet Couns (2012) 0.97
Providers' perceptions and practices regarding BRCA1/2 genetic counseling and testing in African American women. J Genet Couns (2011) 0.89
Intervention completion rates among African Americans in a randomized effectiveness trial for diet and physical activity changes. Cancer Epidemiol Biomarkers Prev (2014) 0.83
Knowledge and accuracy of perceived personal risk in underserved women who are at increased risk of breast cancer. J Cancer Educ (2010) 0.82
A cluster randomized controlled trial to increase breast cancer screening among African American women: the black cosmetologists promoting health program. J Natl Med Assoc (2011) 0.82
Conducting Precision Medicine Research with African Americans. PLoS One (2016) 0.75
Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA (2005) 4.93
Effect of exercise on total and intra-abdominal body fat in postmenopausal women: a randomized controlled trial. JAMA (2003) 3.22
Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 2.97
Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol (2005) 2.70
Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol (2010) 2.53
Application of breast cancer risk prediction models in clinical practice. J Clin Oncol (2003) 2.19
Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. Cancer Res (2004) 2.14
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. Int J Cancer (2008) 2.13
Future health applications of genomics: priorities for communication, behavioral, and social sciences research. Am J Prev Med (2010) 1.98
Effect of a yearlong, moderate-intensity exercise intervention on the occurrence and severity of menopause symptoms in postmenopausal women. Menopause (2004) 1.97
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res (2010) 1.90
Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. Lancet Oncol (2007) 1.89
Trust, benefit, satisfaction, and burden: a randomized controlled trial to reduce cancer risk through African-American churches. J Gen Intern Med (2003) 1.84
Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Lancet Oncol (2006) 1.79
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study. Cancer Epidemiol Biomarkers Prev (2007) 1.75
Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors. J Genet Couns (2004) 1.69
Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst (2007) 1.66
The Cancer Genetics Network: recruitment results and pilot studies. Community Genet (2003) 1.61
Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia. Leuk Lymphoma (2008) 1.60
Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. J Clin Oncol (2008) 1.57
Racial differences in quality of life following prostate cancer diagnosis. Urology (2010) 1.51
Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia. J Clin Oncol (2009) 1.48
Rapid progression of prostate cancer in men with a BRCA2 mutation. Br J Cancer (2008) 1.45
Pentostatin, cyclophosphamide, and rituximab regimen in older patients with chronic lymphocytic leukemia. Cancer (2007) 1.38
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Res (2012) 1.38
Effects of exercise on metabolic risk variables in overweight postmenopausal women: a randomized clinical trial. Obes Res (2005) 1.37
Low rates of acceptance of BRCA1 and BRCA2 test results among African American women at increased risk for hereditary breast-ovarian cancer. Genet Med (2006) 1.34
Effect of exercise on serum androgens in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev (2004) 1.30
Influence of demographic, physiologic, and psychosocial variables on adherence to a yearlong moderate-intensity exercise trial in postmenopausal women. Prev Med (2004) 1.29
Race/ethnicity, physical activity, and quality of life in breast cancer survivors. Cancer Epidemiol Biomarkers Prev (2009) 1.27
Minority recruitment in hereditary breast cancer research. Cancer Epidemiol Biomarkers Prev (2004) 1.27
What does my doctor think? Preferences for knowing the doctor's opinion among women considering clinical testing for BRCA1/2 mutations. Genet Test (2002) 1.25
Recruiting African American women to participate in hereditary breast cancer research. J Clin Oncol (2005) 1.25
Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer. Cancer Discov (2012) 1.25
The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families. Cancer Res (2008) 1.24
Effects of a yearlong moderate-intensity exercise and a stretching intervention on sleep quality in postmenopausal women. Sleep (2003) 1.23
Attitudes about genetic testing and genetic testing intentions in African American women at increased risk for hereditary breast cancer. Genet Med (2005) 1.23
A classification model for BRCA2 DNA binding domain missense variants based on homology-directed repair activity. Cancer Res (2012) 1.21
Satisfaction with genetic counseling for BRCA1 and BRCA2 mutations among African American women. Patient Educ Couns (2006) 1.17
Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients. Br J Haematol (2007) 1.15
Knowledge about genetics among African Americans. J Genet Couns (2007) 1.13
Prescription of tamoxifen for breast cancer prevention by primary care physicians. Arch Intern Med (2006) 1.12
Knowledge, attitudes, and utilization of BRCA1/2 testing among women with early-onset breast cancer. Genet Test (2005) 1.12
Racial differences in medical mistrust among men diagnosed with prostate cancer. Cancer (2009) 1.11
Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status. Cancer Prev Res (Phila) (2011) 1.10
Advice on using over-the-counter nicotine replacement therapy-patch, gum, or lozenge-to quit smoking. Addict Behav (2007) 1.08
Ofatumumab-based chemoimmunotherapy is effective and well tolerated in patients with previously untreated chronic lymphocytic leukemia (CLL). Cancer (2013) 1.07
BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic. J Clin Oncol (2002) 1.06
Developing an academic-community partnership for research in prostate cancer. J Cancer Educ (2006) 1.05
Evaluation of Cancer 101: an educational program for native settings. J Cancer Educ (2010) 1.05
Intentions to participate in genetics research among African American smokers. Cancer Epidemiol Biomarkers Prev (2006) 1.04
Genetic variants of uncertain significance: flies in the ointment. J Clin Oncol (2008) 1.03
Does genomic risk information motivate people to change their behavior? Genome Med (2009) 1.03
Participation rates and representativeness of African Americans recruited to a health promotion program. Health Educ Res (2009) 1.01
Paternal relatives and family history of breast cancer. Am J Prev Med (2006) 0.99
Early use of clinical BRCA1/2 testing: associations with race and breast cancer risk. Am J Med Genet A (2003) 0.99
A randomized trial of a computer-tailored decision aid to improve prostate cancer screening decisions: results from the Take the Wheel trial. Cancer Epidemiol Biomarkers Prev (2010) 0.99
The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers. Cancer Epidemiol Biomarkers Prev (2007) 0.98
Patients' resistance to risk information in genetic counseling for BRCA1/2. Arch Intern Med (2005) 0.97
Low rates of African American participation in genetic counseling and testing for BRCA1/2 mutations: racial disparities or just a difference? J Genet Couns (2012) 0.97
Cultural, economic, and psychological predictors of colonoscopy in a national sample. J Gen Intern Med (2011) 0.97
Testing targeted approaches to enhance Cancer Genetics Network minority recruitment within Asian populations. Community Genet (2008) 0.96
Perceptions of changes in weight among African American breast cancer survivors. Psychooncology (2006) 0.94
Community-centered family health history: a customized approach to increased health communication and awareness. Prog Community Health Partnersh (2011) 0.94
Long-term reactions to genetic testing for BRCA1 and BRCA2 mutations: does time heal women's concerns? J Clin Oncol (2011) 0.94
Breast cancer screening behaviors among African American women with a strong family history of breast cancer. Prev Med (2006) 0.93
Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat (2011) 0.92
Understanding participation by African Americans in cancer genetics research. J Natl Med Assoc (2012) 0.92
The impact of family history of breast cancer and cancer death on women's mammography practices and beliefs. Genet Med (2008) 0.92
Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers. J Clin Oncol (2012) 0.91
Randomized trial of a low-intensity dietary intervention in rural residents: the Rural Physician Cancer Prevention Project. Am J Prev Med (2005) 0.91
Donation intentions for cancer genetics research among African Americans. Genet Test Mol Biomarkers (2012) 0.91
Impact of shortages of injectable oncology drugs on patient care. Am J Health Syst Pharm (2014) 0.90
Personal attributions for melanoma risk in melanoma-affected patients and family members. J Behav Med (2010) 0.89
Differences in cultural beliefs and values among African American and European American men with prostate cancer. Cancer Control (2007) 0.89
Sociocultural predictors of breast cancer risk perceptions in African American breast cancer survivors. Cancer Epidemiol Biomarkers Prev (2007) 0.88